SILENT REFLUX • LPR • Laryngopharyngeal Reflux
Do any of these sound familiar?
Read through the list. If you recognize yourself in three or more of these, keep reading — there is a name for what you are experiencing.
• Clearing your throat constantly — multiple times an hour
• Waking up with a hoarse or rough voice that improves during the day
• A sensation of mucus or something stuck at the back of your throat
• A chronic cough that appeared from nowhere — especially when talking or after meals
• The feeling of a lump or ball in your throat that won’t shift (globus)
• Your voice fatigues quickly — tires after a phone call or conversation
• Difficulty swallowing — food or pills feel like they catch
• Symptoms triggered by cold air, strong smells, talking, or laughing
• Episodes of sudden throat tightening or choking — especially at night
• Little or no heartburn — yet the throat symptoms persist
• Tried acid reflux medication (PPIs) for months — little to no improvement
• Told tests are normal, yet something clearly feels wrong
If you recognized yourself in that list, there is a name for what you are experiencing. It is called laryngopharyngeal reflux — LPR — and it is one of the most commonly missed diagnoses in modern medicine. Not because it is rare. Because it is silent.
Unlike classic acid reflux or GERD, LPR rarely produces heartburn. There is no obvious burning sensation to point a finger at. Instead, the damage happens quietly — stomach contents, including an enzyme called pepsin, reaching your throat and voice box during the night or after meals, depositing on tissue that was never designed to handle them. The result is a cascade of chronic, bewildering symptoms that send people from their GP to an allergist to an ENT to a gastroenterologist and back again — often without a clear answer.
“The absence of heartburn does not mean the absence of reflux. In LPR, the throat bears the burden while the stomach stays silent.”
Why Pepsin Is the Real Problem
Most people — and many clinicians — think of acid reflux as an acid problem. Which is why proton pump inhibitors (PPIs) are the default treatment. Block the acid, fix the reflux. Except in LPR, this approach misses the primary offender entirely.
The real villain is pepsin — a digestive enzyme that is stable and biochemically active at a pH as high as 6.5. That means even weakly acidic or near-neutral stomach contents can carry pepsin to your larynx and pharynx, where it deposits on delicate tissue and remains active. Every sip of coffee, every acidic food, every slight dip in pH reactivates it — triggering a fresh inflammatory response on tissue that has no natural defense mechanism against it. Unlike your esophagus, your throat has no mucus layer, no bicarbonate buffer, and no ability to clear pepsin through peristalsis.
THE RESEARCH
Johnston et al. (2007) established pepsin as a causative agent in LPR laryngeal injury, demonstrating that pepsin enters laryngeal cells via receptor-mediated endocytosis and remains detectable long after the reflux event itself has passed. A 2012 study by Koufman and Johnston showed that alkaline water at pH 8.8 produces complete and irreversible pepsin denaturation — a finding with significant implications for both dietary and therapeutic management.
This explains why so many people with LPR take PPIs for months and feel no better. The acid is being suppressed. The pepsin is not.
The Gut Connection Most People Don’t Know About
LPR is not just a mechanical plumbing problem. The emerging science tells a more complex story — one that connects the composition of your gut microbiome to the inflammation in your throat.
The esophageal microbiome in LPR patients is consistently dysbiotic — shifted away from gram-positive commensal bacteria toward gram-negative Proteobacteria that produce lipopolysaccharide (LPS), an inflammatory bacterial toxin. This LPS burden activates TLR4 signaling, drives NF-kB inflammatory cascades, and directly increases mucosal hypersensitivity in the larynx and esophagus. In plain terms: the wrong bacteria in your gut and throat are amplifying your inflammatory response, making every pepsin exposure more damaging than it would otherwise be.
Helicobacter pylori — present in roughly 44% of the global population — adds another layer. It disrupts gastric motility, alters gastric acid dynamics in ways that paradoxically worsen reflux, and significantly reduces the bioavailability of certain medications. Multiple studies have linked H. pylori eradication to meaningful LPR symptom improvement.
The Gut–Throat Pathway — A Simplified Overview
• Dysbiotic gut bacteria produce LPS, which drives systemic inflammation
• Inflammatory signaling increases intestinal permeability — “leaky gut”
• More LPS enters circulation, amplifying mucosal hypersensitivity in the throat and larynx
• The laryngeal mucosa becomes more reactive to pepsin, bile acids, and mechanical triggers
• Symptoms persist even as reflux events decrease — because the tissue itself is sensitized
Why You Were Told “Everything Is Normal”
This is perhaps the most frustrating part of the LPR story. Standard medical workups for throat symptoms — including laryngoscopy, endoscopy, and pH testing — can miss LPR because they are often designed to detect GERD, not LPR. Laryngoscopy shows inflammation but not its cause. Standard pH monitoring measures acid in the esophagus, not in the laryngopharynx where the actual damage is occurring. And because there is no heartburn, the clinical picture doesn’t fit the standard reflux template.
A validated clinical scoring tool called the Reflux Symptom Index (RSI) gives a far more sensitive picture. A score above 13 across nine symptom categories is considered clinically significant for LPR — and most people who have struggled with unexplained throat symptoms for months or years score well above this threshold when they first encounter it.
The Ten Pathways Driving Your Symptoms
What makes LPR genuinely complex — and what makes single-target treatments so often insufficient — is that it is perpetuated by multiple simultaneous physiological mechanisms. A precision medicine approach addresses all of them.1
Pepsin Deposition and Reactivation
Pepsin deposited on laryngeal tissue during reflux events remains active and is repeatedly reactivated by acidic foods and drinks throughout the day.
Microbiome Dysbiosis
Disrupted oral, laryngeal, esophageal, and gastric microbiomes amplify inflammation and perpetuate the conditions that allow reflux to continue.
Mucosal Barrier Dysfunction
Leaky gut drives systemic LPS burden, increasing mucosal hypersensitivity throughout the upper aerodigestive tract.
Vagal Tone Dysregulation
Reduced heart rate variability and impaired vagal function are associated with lower esophageal sphincter dysfunction and laryngeal hypersensitivity.
Motility Impairment
Delayed gastric emptying, SIBO, and impaired esophageal peristalsis increase the frequency and volume of reflux events.
Histamine and Mast Cell Activation
Mast cell hyperresponsiveness in the laryngeal mucosa amplifies tissue inflammation and directly reduces esophageal sphincter pressure.
Bile Acid Reflux (DGER)
Duodenal bile acids cause mucosal injury independent of pH — a mechanism entirely unaddressed by acid suppression therapy.
HPA Axis Dysregulation and Stress
Cortisol directly reduces esophageal sphincter pressure, increases intestinal permeability, and suppresses mucosal immune defense.
Laryngeal Hypersensitivity Syndrome
After months of pepsin injury, the sensory nerves of the larynx become sensitized — producing symptoms even when active reflux is minimal or absent.
Chronic Neuroinflammation
NF-kB activation drives ongoing cytokine release in laryngeal tissue, maintaining inflammation and sensory sensitization long after the initiating trigger.
What Actually Helps
The evidence for what works in LPR has advanced considerably in the past decade — and it points away from indefinite acid suppression and toward a multi-targeted approach that addresses the root causes simultaneously.
Alkaline water — the most underestimated intervention
A landmark 2012 study demonstrated that water at pH 8.8 produces complete and irreversible denaturation of pepsin — destroying its enzymatic activity permanently. Two liters of alkaline water daily is both the cheapest and one of the most evidence-based interventions available for LPR, yet it remains almost entirely absent from standard management guidelines.
Dietary change — not just trigger avoidance
A 2017 comparative effectiveness study by Zalvan and colleagues demonstrated that a plant-based, alkaline dietary pattern produced RSI score improvements equivalent to PPI therapy in mild to moderate LPR — without the microbiome disruption, magnesium depletion, and rebound acid hypersecretion that accompany long-term PPI use. The dietary approach works not by suppressing acid but by reducing the pH of the refluxate, limiting pepsin reactivation, and supporting the gut microbiome that drives mucosal recovery.
Targeted microbiome support
Lactobacillus reuteri DSM 17938 has demonstrated H. pylori suppression activity and upper GI mucosal support in clinical trials. Saccharomyces boulardii CNCM I-745 supports restoration of commensal bacterial populations and reduces the Proteobacteria overgrowth that characterizes LPR-associated dysbiosis. Comprehensive stool microbiome analysis — not the standard culture-based tests — provides the map that guides targeted intervention.
Mucosal repair — the often-skipped step
Zinc carnosine at 75 mg twice daily has demonstrated significant esophageal and gastric mucosal protective effects in randomized controlled trials, inhibiting pepsin activity at the mucosal surface and supporting tight junction protein restoration. DGL (deglycyrrhizinated licorice), L-glutamine, colostrum, and sodium alginate work across complementary mechanisms to rebuild the mucosal barrier that acid suppression alone never repairs.
“The goal is not to suppress a symptom. The goal is to restore the conditions in which the tissue can heal itself.”
Vagal tone restoration — often the missing piece
The vagus nerve governs esophageal motility, sphincter tone, gastric emptying, and the cough reflex. Diaphragmatic breathing for 10–15 minutes daily directly stimulates vagal afferents, measurably improving heart rate variability and lower esophageal sphincter pressure. It is free, has no side effects, and has clinical evidence behind it — yet it is prescribed in almost no LPR management plans. For those with laryngeal hypersensitivity syndrome overlay, laryngeal retraining therapy with a speech pathologist is not optional — it is the most effective single intervention available for neurogenic cough and persistent globus.
How Long Does Recovery Take?
This depends significantly on how long symptoms have been present, whether structural factors are involved, and how much neural sensitization has developed. With a comprehensive approach:
Typical Recovery Timeline — With Full Protocol Adherence
Weeks 3–4
Morning hoarseness and throat clearing frequency typically begin to reduce first
Weeks 6–8
Globus sensation and post-nasal drip improve; voice quality stabilizes
Weeks 10–12
RSI score often normalizes below 13 in straightforward cases
Months 4–6
Full mucosal tissue recovery and microbiome normalization; most patients can reduce their supplement protocol to a maintenance stack
Ongoing
Alkaline water, dietary principles, and HOCL remain as lifestyle foundations rather than treatments
The single most important variable is not which supplements you take — it is whether you address the problem across all its active pathways simultaneously, rather than targeting one mechanism at a time and waiting to see if it works before trying the next. The pathways reinforce each other. The interventions need to match that.
A Note on HOCL — The Emerging Therapeutic
Stabilized hypochlorous acid (HOCL) at 100 ppm is attracting significant clinical interest in LPR management for a straightforward reason: it directly inactivates pepsin through oxidation of its active site, operates as a broad-spectrum antimicrobial against the laryngeal and esophageal pathobionts driving dysbiosis, and disrupts biofilm communities in the upper GI tract — all through a mechanism that is biocompatible with human mucosal cells at this concentration.
When used as a swish-gargle-swallow protocol in the fasted state, stabilized HOCL contacts the oral cavity, laryngopharynx, and upper esophageal mucosa before food, coffee, or other triggers arrive — inactivating pepsin at the mucosal surface and reducing the pathogen burden that perpetuates mucosal inflammation. The mechanistic logic is sound, the safety profile is well-established, and the clinical observations from practitioners using it in LPR management are increasingly consistent.
Where to Start
If this article has given a name to something you have been experiencing for months or years, the most important next step is a proper clinical assessment — not another round of empirical PPI therapy, but a structured evaluation using validated tools like the RSI, comprehensive microbiome analysis, and laryngoscopy with Reflux Finding Score assessment.
A precision medicine approach to LPR is not a single supplement or a simple dietary swap. It is a systematic, evidence-based protocol that maps your individual physiological drivers and addresses them concurrently. The research supports it. The outcomes are real. And for most people with this condition, a full resolution of symptoms — not just management — is an achievable clinical goal.
You have not been imagining it. Your throat has been telling you something. It is time to listen.
PRECISION MEDICINE LPR PROTOCOL
Ready to work with someone who understands what’s actually happening?
Our LPR protocol is built on the science in this article — a structured, multi-pathway approach designed to address root causes, not suppress symptoms indefinitely. If you scored above 13 on the RSI or recognized yourself in these pages, a clinical assessment is the right next step.
To request an assessment or learn more about the protocol, contact us at:
Your information is private and will never be shared.
Medical Disclaimer
This article is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. The information presented reflects current clinical research and precision medicine principles but should not replace individualized assessment and care from a qualified practitioner.
Precision Health Journal — Where the science of longevity meets the practice of living well. — © 2026 —
Clinical content reviewed March 2026 — Dr. Lily Woods, Phd
